Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Eye implant receives FDA approval for correcting mild myopia

April 13, 1999

PhotoVision in-licenses novel technology for development of AMD treatment

April 7, 1999

Xalatan approved in Japan for glaucoma and ocular hypertension

March 16, 1999

Licensing opportunity from the NIH: antiinflammatory cytokine

March 4, 1999

Placebo-controlled study supports the efficacy of Alrex in seasonal allergic conjunctivitis

March 1, 1999

Worldwide strategic alliance established by Agennix and Santen for lactoferrin

Feb. 26, 1999

Novel antioxidant/antiproliferative NSAID esters and amides designed by Alcon

Feb. 19, 1999

CoCensys enters research agreements with Senju and Parke-Davis

Feb. 18, 1999

FDA says KeraVision's treatment for myopia approvable

Feb. 17, 1999

Patient enrollment completed in loteprednol/antibiotic combination study

Feb. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...